als preclinical drug discovery and therapy development: finally, real progress!
Published 3 years ago • 2.4K plays • Length 53:25Download video MP4
Download video MP3
Similar videos
-
55:24
challenges in drug development for als
-
45:00
problems and progress in als clinical trials
-
44:48
the expanding landscape of therapeutic targets in als clinical trials
-
28:58
advancements in preclinical drug development for als: theo hatzipetros, ph.d.
-
1:40:53
dr. jeff rothstein md phd of johns hopkins re personalized medicine in als
-
20:00
a view on als drug discovery - learnings from the front lines of translational disease modeling
-
57:47
pre-clinical modelling for drug discovery in amyotrophic lateral sclerosis
-
57:40
early markers of disease in familial als
-
2:14
als tdi: the drug discovery engine for als
-
42:10
brainiacs: the unlikely suspect: neurons not responsible for als?
-
1:00:01
conversations that matter: new facts about the brain - ms, als & parkinson’s disease
-
4:17
stem cell implications for als (amyotrophic lateral sclerosis)
-
3:52
precision medicine program at als tdi
-
1:12:50
gene based therapies for als by dr. bob brown
-
21:12
optimising preclinical drug discovery for mnd – an academic / industrial collaborative approach
-
1:00:58
als starts at the nuclear pore: insights and therapy for als and dementia by dr. jeff rothstein
-
23:04
als 101: clinical trials
-
1:00:04
therapies in als - symptomatic & pre-symptomatic biomarkers for als therapy development
-
3:53
driving toward a cure for als | science: out of the box